Perspective · 4 Mar 2025
Research articlePublished 2013
Driving, Opioid-maintenance, and Co-medications: A Comprehensive Assessment of 22 Cases
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Patients in stable Opioid Maintenance Treatment (OMT) for opioid-dependence are, as a rule, considered fit to drive a car. Polypharmacotherapy, however, is common in opioid-dependent patients, and its association with driving fitness is not well known. Therefore, we examined driving fitness of 22 OMT patients of whom the majority were multidrug-treated patients. Material and methods: The assessment included a standard on-road driving test, clinical neurological examination, and cognitive driving-related tests. The OMT patients were grouped on the basis of their psychoactive medications into two groups. The first group was considered to have a low probability for drug-related driving impairment (n=10). This group included patients treated with opioid agonist alone or along with the second generation antidepressant or lithium. The second group included patients with probable drug-related driving impairment (n=12). All patients in this group were given at least one benzodiazepine (BZD) drug, Results: In neurological evaluation all OMT patients met the basic requirements for driving. In the driving test, all patients in the group with ‘improbable drug-related driving impairment’ and all except one in the group with ‘probable drug-related driving impairment’ were found fit to drive. However, in the driving test total score and two driving-related cognitive tests, the group with ‘probable drug-related driving impairment’ scored significantly lower than the improbable group (p=0.021, 0.001, and 0.028, respectively). Two cases with ‘probable drug-related driving impairment’ are described in detail. Conclusions: The results of this case series give support for the notion that OMT patients in stable treatment, in general, are fit to drive. When assessing the driving fitness of individual OMT patients with polypharmacy, combining pharmacological and non-pharmacological information is essential, as shown by two case descriptions.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alcoholism & Drug Dependence.
Research article · 4 Mar 2025
Genetic and Epigenetic Markers Associated with Alcohol Dependence: A Systematic Analysis
Short communication · 4 Mar 2025
Patterns of Polysubstance Abuse in Urban Populations: Implications for Intervention Strategies
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alcoholism & Drug Dependence
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pekka Rapeli”
- BylineArticles whose byline prints “Pekka Kuikka”
- BylineArticles whose byline prints “Hanna Sillanpää”
- BylineArticles whose byline prints “Carola Fabritius”
- BylineArticles whose byline prints “Kaarlo Simojoki”
- BylineArticles whose byline prints “Hely Kalska”
- BylineArticles whose byline prints “Pirjo Lillsunde”
- BylineArticles whose byline prints “Hannu Alho”
